Pfizer Inc (PFE)
Gross profit margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit (ttm) | US$ in thousands | 41,722,000 | 35,525,000 | 27,027,000 | 28,281,000 | 30,018,000 | 39,003,000 | 52,949,000 | 62,128,000 | 65,570,000 | 65,030,000 | 62,576,000 | 55,828,000 | 50,522,000 | 45,185,000 | 40,666,000 | 38,258,000 | 37,537,000 | 38,852,000 | 39,328,000 | 40,496,000 |
| Revenue (ttm) | US$ in thousands | 63,627,000 | 60,113,000 | 55,643,000 | 55,094,000 | 58,497,000 | 68,538,000 | 77,944,000 | 92,952,000 | 100,331,000 | 99,879,000 | 101,335,000 | 92,570,000 | 81,491,000 | 69,337,000 | 57,374,000 | 50,198,000 | 47,644,000 | 48,648,000 | 49,197,000 | 50,660,000 |
| Gross profit margin | 65.57% | 59.10% | 48.57% | 51.33% | 51.32% | 56.91% | 67.93% | 66.84% | 65.35% | 65.11% | 61.75% | 60.31% | 62.00% | 65.17% | 70.88% | 76.21% | 78.79% | 79.86% | 79.94% | 79.94% |
December 31, 2024 calculation
Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $41,722,000K ÷ $63,627,000K
= 65.57%
Pfizer Inc's gross profit margin has exhibited fluctuations over the period from March 31, 2020, to December 31, 2024. Initially, the company maintained a high gross profit margin hovering around 79%, indicating strong profitability in the early quarters. However, there was a notable decline in the margin in subsequent quarters, reaching a low of 48.57% by June 30, 2024.
From June 30, 2024, to December 31, 2024, there was a significant improvement in the gross profit margin, rebounding to 65.57%. It is important to note that the gross profit margin is a key indicator of a company's efficiency in managing production costs and pricing its products effectively.
The downward trend in the gross profit margin from June 30, 2021, to December 31, 2024, may indicate challenges faced by Pfizer Inc in maintaining profitability, which could be attributed to various factors such as increased production costs, pricing pressures, or changes in product mix. Monitoring and analyzing the gross profit margin trends can provide valuable insights into the company's operational performance and competitiveness in the pharmaceutical industry.
Peer comparison
Dec 31, 2024